Dexamethasone suppression of corticosteroid secretion: Evaluation of the site of action by receptor measures and functional studies

Psychoneuroendocrinology

Volumn 25, Issue 2, 2000, Pages 151-167

  Cole, Michael A ^a   Kim, Paul J ^a   Kalman, Brian A ^a   Spencer, Robert L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Corticosteroid receptors; Corticosterone; Hippocampus; HPA axis; Pituitary; Rats

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORTICOSTEROID RELEASE; DEXAMETHASONE SUPPRESSION TEST; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; RECEPTOR OCCUPANCY; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033990897     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00045-1     Document Type: Article

References (52)

1. APA Task Force on Laboratory Tests in Psychiatry, 1987. The dexamethasone suppression test. An overview of its current status in psychiatry. Am. J. Psychiatry 144, 1253-1268.
2. Asnis G.M., Friedman J.M.H., Miller A.H. Plasma dexamethasone and cortisol levels in depressed outpatients. J. Affect. Disord. 16:1989;5-10.
3. Barden N., Stec I.S.M., Montkowski A., Holsboer F., Reul J.M.H.M. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology. 66:1997;212-220.
4. Bradbury M.J., Akana S.F., Dallman M.F. Roles of type I and type II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology. 134:1994;1286-1296.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Calogero A.E., Kamilaris T.C., Johnson E.O., Tartaglia M.E., Chrousos G. Recovery of the rat hypothalamus-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone. Endocrinology. 127:1990;1574-1579.
7. Carroll B.J. The dexamethasone suppression test for melancholia. Br. J. Psychiat. 140:1982;292-304.
8. Chou Y.C., Luttge W.G. Activated Type II receptors in brain cannot rebind glucocorticoids: relationship to progesterone's antiglucocorticoid actions. Brain. Res. 361:1988;212-216.
9. de Kloet R., van der Vies J., de Wied D. The site of suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology. 94:1974;61-73.
10. de Kloet R., Wallach G., McEwen B.S. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 96:1975;589-609.
11. de Kloet R., Burbach P., Mulder G.H. Localization and role of transcortin-like molecules in the anterior pituitary. Mol. Cell. Endocrinol. 7:1977;261-273.
12. de Kloet R., Oitzl M.S., Joels M. Functional implications of brain corticosteroid receptor diversity. Cell. Mol. Neurobiol. 13:1993;433-455.
13. de Wied D. The site of the blocking action of dexamethasone on stress-induced pituitary ACTH release. J. Endocrin. 29:1964;29-37.
14. Feldman S., Conforti N., Chowers I. Effect of dexamethasone on adrenocortical responses in intact and hypothalamic deafferented rats. Acta Endocrinol. 73:1973;660-664.
15. Feldman S., Conforti N. Adrenocortical responses in dexamethasone-treated rats with septal, preoptic and combined hypothalamic lesions. Horm. Res. 12:1980;289-295.
16. Feldman S., Conforti N. Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity. Neuroendocrinology. 30:1980;52-55.
17. Feldman S., Siegel R.A., Weidenfeld J., Conforti N., Melamed E. Role of medial forebrain bundle catecholaminergic fibers in the modulation of glucocorticoid negative feedback. Brain Res. 260:1983;297-300.
18. Feldman S., Weidenfeld J. Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion. Psychoneuroendocrinology. 16:1991;397-405.
19. Feldman S., Weidenfeld J. The dorsal hippocampus modifies the negative feedback effect of glucocorticoids on the adrenocortical and median eminence CRF-41 responses to photic stimulation. Brain. Res. 614:1993;227-232.
20. Gispen-de Wied C.C., D'Haenen H., Verhoeven W.M.A. et al. Inhibition of the pituitary-adrenal axis with dexamethasone and cortisol in depressed patients and healthy subjects: a dose-related study. Psychoneuroendocrinology. 18:1993;191-204.
21. Gispen-de Wied C.C., Jansen L.M.C., Wynne H.J. et al. Differential effects of hydrocortisone and dexamethasone on cortisol suppression in a child psychiatric population. Psychoneuroendocrinology. 23:1998;295-305.
22. Gispen-de Wied C.C., Westenberg H.G.M., Thijssen J.H.H., van Ree J.M. The dexamethasone and cortisol suppression test in depression: beta-endorphin as a useful marker. Psychoneuronendocrinology. 12:1987;355-366.
23. Guillaume-Gentil C., Rohner-Jeanrenaud F., Abramo F., Bestetti G.E., Giovanni L.R., Jeanrenaud B. Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology. 126:1990;1873-1879.
24. Haracz J.L., Minor T.R., Wilkins J.N., Zimmerman E.G. Learned helplessness: an experimental model of the DST in rats. Biol. Psychiat. 23:1988;388-396.
25. Hassan A.H., von Rosenstiel P., Patchev V.K., Holsboer F., Ameida O.F. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp. Neurol. 140:1996;43-52.
26. Hatzinger M., Reul J.M.H.M., Landgraf R., Holsboer F., Neumann I. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging. Neuroendocrinology. 64:1996;349-356.
27. Heit S., Owens M.J., Plotsky P., Nemeroff C.B. Corticotropin-releasing factor, stress, and depression. Neurosci. 3:1997;186-194.
28. Holsboer F. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects. J. Steroid Biochem. 19:1983;251-257.
29. Hornsby C.D., Grootendorst J., de Kloet E.R. Dexamethasone does not prevent seven-day ADX-induced apoptosis in the dentate gyrus of the rat hippocampus. Stress. 1:1996;51-64.
30. Kathol R.G., Jaeckle R.S., Lopez J.F., Meller W.H. Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycamia in patients with depression. Br. J. Psychiatry. 155:1989;468-478.
31. Klein H.E., Berger M. The pitfalls of the dexamethasone suppression test: A biological marker for endogenous depression? Hum. Psychopharmacol. 2:1987;85-103.
32. Litwack G. The glucocorticoid receptor at the protein level. Cancer Res. 48:1988;2636-2640.
33. Loose D.S., Do Y.S., Chen T.L., Feldman D. Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland. Endocrinology. 107:1980;137-146.
34. Maes M., Meltzer H.Y., D'Hondt P., Cosyns P., Blockx P. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology. 20:1995;149-167.
35. Meijer O.C., de Lange E.C.M., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 139:1998;1789-1793.
36. Miller A.H., Spencer R.L., Pulera M., Kang S., McEwen B.S., Stein M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. Biol. Psychiatry. 32:1992;850-869.
37. Murphy B.E., Dhar V., Ghadirian A.M., Chouinard G., Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J. Clin. Psychopharmacol. 11:1991;121-126.
38. O'Sullivan B.T., Hunt G.E., Johnson G.F., Caterson I.D. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results. Biol. Psychiatry. 25:1989;739-754.
39. Pardridge W.M. Transport of protein-bound hormones into tissues in vivo. Endocr. Rev. 2:1981;103-123.
40. Pepin M.C., Pothier F., Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42:1992;991-995.
41. Pepin M.C., Pothier F., Barden N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature. 355:1992;725-728.
42. Reul J.M.H.M., van den Bosch F.R., de Kloet E.R. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J. Endocr. 115:1987;459-467.
43. Ribeiro S.C.M., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in dexamethasone: a meta-analysis. Am. J. Psychiatry. 150:1993;1618-1629.
44. Rupprecht R., Kornhuber J., Wodarz N. et al. Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone. Biol. Psychiatry. 29:1991;1099-1109.
45. Sapolsky R.M., Plotsky P.M. Hypercortisolism and its possible neural bases. Biol. Psychiatry. 27:1990;937-952.
46. Spencer R.L., Young E.A., Choo P.H., McEwen B.S. Adrenal steroid type I and II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res. 514:1990;37-48.
47. Stec I., Barden N., Reul J.M., Holsboer F. Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J. Psychiat. Res. 28:1994;1-5.
48. Von Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J. Neuroendocrinol. 1:1989;485-488.
49. Von Bardeleben U., Holsboer F., Stalla G.K., Muller O.A. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 37:1985;1613-1618.
50. Warembourg M. Radioautographic study of the rat brain and pituitary after injection of 3H dexamethasone. Cell. Tiss. Res. 161:1975;183-191.
51. Weidenfeld J., Feldman S. Glucocorticoid feedback regulation of adrenocortical responses to neural stimuli: role of CRF-41 and corticosteroid type I and type II receptors. Neuroendocrinology. 58:1993;49-56.
52. Young E.A., Haskett R.F., Murphy-Weinberg V., Watson S.J., Akil H. Loss of glucocorticoid fast feedback in depression. Arch. Gen. Psychiatry. 48:1991;693-699.